Waiv

Private

AI precision testing company spun out from Owkin, applying deep neural network analysis to digitized biopsy slides for oncology biomarker discovery, detection, and treatment-response prediction

Founders Meriem Sefta

CEO Meriem Sefta

Company

Founded

2026

Headquarters

Paris, France

Financials

Total Funding

$33M

Sectors

Artificial Intelligence Healthtech Biotech

wearewaiv.com

Funding History

1 round

Seed Mar 12, 2026

$33M

OTB Ventures (Lead) Alpha Intelligence Capital Serena Data Ventures Karista SistaFund

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.